Navigation Links
JCI early table of contents for Mar. 1, 2013
Date:3/1/2013

A coordinated response to cardiac stress

Myocardial hypertrophy, a thickening of the heart muscle, is an adaptation that occurs with increased stress on the heart, such as high blood pressure. As the heart muscle expands, it also requires greater blood flow to maintain access to oxygen and nutrients, necessitating an expansion of the cardiac vasculature. In this issue of the Journal of Clinical Investigation, Daniela Tirziu and researchers at Yale University identified a molecular mechanism by which the growth of new blood vessels (angiogenesis) and heart muscle growth are coordinated. Using a mouse model of myocardial hypertrophy, Tirziu and colleagues determined that nitric oxide triggers the destruction of a protein known as RGS4. Nitric oxide typically drives physiological changes associated with the relaxation of blood vessels, while RGS4 attenuates the activity of a cellular signaling pathway that promotes cardiac growth. These findings reveal how increases in heart muscle and blood vessel growth are coordinated, linking changes in vasculature to changes in heart size.

TITLE:
NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth

AUTHOR CONTACT:
Daniela Tirziu
Yale School of Medicine, New Haven, CT, USA
Phone: 203-737-2627; Fax: 203-737-6236; E-mail: daniela.tirziu@yale.edu

View this article at: http://www.jci.org/articles/view/65112?key=6e03e6b35dba375333ec


A nanogel-based treatment for lupus

Systemic lupus erythematosus (SLE) is disease in which the immune system mistakenly attacks healthy tissues, resulting in inflammation and tissue damage. Current treatments are focused on suppression of the immune system, but these therapies can leave patients vulnerable to infection. In this issue of the Journal of Clinical Investigation, Tarek Fahmy and colleagues at Yale University report the development of a nanogel-based delivery system that targets an immunosuppressive drug (mycophenolic acid) directly to tissues associated with immune cells. A nanogel is composed of a polymer containing pores that can be loaded with drug compounds. Fahmy and colleagues tested the mycophenolic acid-loaded nanogel in a mouse model of lupus. Mice treated with the nanogel lived longer than untreated mice or mice treated with mycophenolic acid alone. Additionally, the onset of kidney damage, a common complication of lupus, was delayed in nanogel-treated mice. These studies suggest that nanogel-based therapies may be useful in the treatment of SLE.

TITLE:
Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus

AUTHOR CONTACT:
Tarek Fahmy
Yale University, New Haven, CT, USA
Phone: 203-512-1699; Fax: 203-432-1043; E-mail: tarek.fahmy@yale.edu

View this article at: http://www.jci.org/articles/view/65907?key=2a162626b2b9eb600213


ALSO IN THIS ISSUE

TITLE:
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients

AUTHOR CONTACT:
Young Kim
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Phone: 410-550-0460; E-mail: ykim76@jhmi.edu

View this article at: http://www.jci.org/articles/view/60083?key=88009f6e6231c06368aa

TITLE:
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer

AUTHOR CONTACT:
Roland Ullrich
Max Planck Institute for Neurological Research, Cologne, DEU
Phone: 49-151-62402043; E-mail: ullrich@nf.mpg.de

View this article at: http://www.jci.org/articles/view/65385?key=fa01fd04531a6fc7b015

TITLE:
Blockade of individual Notch ligands and receptors controls graft-versus-host disease

AUTHOR CONTACT:
Ivan Maillard
University of Michigan, Ann Arbor, MI, USA
Phone: 734-763-3599; Fax: 734-615-5493; E-mail: imaillar@umich.edu

View this article at: http://www.jci.org/articles/view/65477?key=3af59faf261abc013250

TITLE:
Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis

AUTHOR CONTACT:
Ji Ming Wang
LMI, CIP, CCR, FNLCR, Frederick, MD, USA
Phone: 301-846-6979; Fax: 301-846-7042; E-mail: wangji@mail.nih.gov

View this article at: http://www.jci.org/articles/view/65569?key=e56df33d5f5e2f2543cb

TITLE:
IgG4 subclass antibodies impair anti-tumor immunity in melanoma

AUTHOR CONTACT:
Sophia N Karagiannis
King's College London, London, GBR
Phone: 44-020-7188-6355; Fax: 44-020-7188-8050; E-mail: sophia.karagiannis@kcl.ac.uk

View this article at: http://www.jci.org/articles/view/65579?key=42201b518523668ff53c

TITLE:
Bone marrow mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression

AUTHOR CONTACT:
Irene Ghobrial
Dana-Farber Cancer Institute, Boston, MA, USA
Phone: 617-632-4198; E-mail: irene_ghobrial@dfci.harvard.edu

View this article at: http://www.jci.org/articles/view/66517?key=207bc7184c041ef9a62a


'/>"/>

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Related medicine news :

1. New Stool Test Might Aid in Early Detection of Colon Cancer
2. An Early Start for Your Child with Autism
3. Early Study Finds Some Promise for Lung Cancer Vaccine
4. Treat Rheumatoid Arthritis Early and Aggressively: Guidelines
5. JCI early table of contents for April 9, 2012
6. Eye Tremors May Aid Early Diagnosis of Parkinsons: Study
7. Nearly 1 in 4 grandparents store prescription medicines where children can easily find them
8. First contact: Early intervention key in diagnosis and treatment of serious mental illness
9. Brain Tumor Vaccine Shows Promise in Early Trial
10. Role of Screening, Monitoring in Early Kidney Disease Unclear
11. Detecting malaria early to save lives: New optical technique promises rapid and accurate diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... ... On Saturday, October 21, the Health & Wellness Center at Florida Hospital ... for the American Heart Association Heart Walk. Teams of up to 10 people can ... their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. on Saturday, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ... Aspen Surgical facility in Las Piedras, Puerto ... scalpels and blades. ... that the facility sustained minor structural damage, temporary loss ... Maria. Repairs have been completed, manufacturing operations have resumed, ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
Breaking Medicine Technology: